Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;9(2):75-80.
doi: 10.1007/BF00265382.

Characteristics of in vitro antiproliferation activity of human interferon-beta

Characteristics of in vitro antiproliferation activity of human interferon-beta

T Kataoka et al. Cancer Chemother Pharmacol. 1982.

Abstract

We compared the in vitro antiproliferative activity of highly purified interferon (IFN)-beta (greater than 10(7) U protein/mg in antiviral activity) with that of IFNs-alpha and lymphoblastoid, using human cells of malignant and non-malignant origin. IFN-beta was the least active of three IFNs in suppressing Daudi cell proliferation. Three hematological cells other than Daudi cells cultivated in suspension were insensitive to each of three IFNs. IFN-beta was more active than IFNs-alpha and lymphoblastoid in suppressing all eight epithelioid cells tested and, particularly with respect to five epithelioid cells sensitive to IFN, IFN-beta was seven to 49 times as active as IFN-alpha. These results indicate that suppression of cell proliferation by IFN depends not only on the target cell species but also on the IFN species, and emphasize the need for careful selection of the most appropriate IFN species in therapy. We found that the antiproliferative characteristics of the present IFN-beta preparation were consistent with those reported previously, supporting the idea that IFN-beta molecules in the present preparation were responsible for suppressing cell proliferation. The antiproliferation activity of our preparation was species-specific but not selective for cells of malignant origin; it was absorbable by IFN-sensitive but not by IFN-insensitive cells; and it was achieved by a cytostatic effect.

PubMed Disclaimer

References

    1. Cancer Res. 1981 Jan;41(1):244-9 - PubMed
    1. Cancer Treat Rev. 1980 Dec;7(4):253-6 - PubMed
    1. Eur J Cancer Clin Oncol. 1981 Sep;17(9):949-67 - PubMed
    1. J Gen Virol. 1977 Jun;35(3):573-7 - PubMed
    1. J Natl Cancer Inst. 1980 Nov;65(5):963-6 - PubMed

Publication types